Showing results (121-130 of 163) with videos related to

Sort By:
Pageof 17
The American Journal of Surgical Pathology|February 22, 2026
International Society of Urological Pathology (ISUP) Consensus Conference on Precursor Lesions: Working Group 4 Precursor Lesions of Testis Results of a Premeeting SurveyFelix Bremmer, Maurizio Colecchia, Katrina Collins, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2015
TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtypeA Ari Hakimi, Satish K Tickoo, Anders Jacobsen, et al.
Cancer|September 25, 2020
Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trialDarren R Feldman, Yasser Ged, Chung-Han Lee, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 14, 2019
Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 casesLiwei Jia, Maria I Carlo, Hina Khan, et al.
Histopathology|May 21, 2022
WHO 2022 landscape of papillary and chromophobe renal cell carcinomaJoão Lobo, Riuko Ohashi, Mahul B Amin, et al.
The Journal of Pathology|March 7, 2019
Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladderSumit Isharwal, Wenhuo Hu, Judy Sarungbam, et al.
Endocrine Pathology|September 22, 2021
TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical CarcinomasSounak Gupta, Helen Won, Kalyani Chadalavada, et al.
Cancer Cell|January 15, 2016
An Integrated Metabolic Atlas of Clear Cell Renal Cell CarcinomaA Ari Hakimi, Ed Reznik, Chung-Han Lee, et al.
The American Journal of Surgical Pathology|May 29, 2019
PD-L1 Expression in Urothelial Carcinoma With Predominant or Pure Variant Histology: Concordance Among 3 Commonly Used and Commercially Available AntibodiesHenning Reis, Rene Serrette, Jennifer Posada, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
Phase II Trial and Correlative Genomic Analysis of Everolimus Plus Bevacizumab in Advanced Non-Clear Cell Renal Cell CarcinomaMartin H Voss, Ana M Molina, Ying-Bei Chen, et al.
Pageof 17